Article · 26 May 2026
Research articlePublished 30 Sep 2015
Synergistic inhibition of drug resistant breast cancer cells growth by the combination of luteolin and tamoxifen involves Nrf2 downregulation
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Elevated expression of NF-E2-related factor 2 (Nrf2), a nuclear transcription factor, is a frequent genetic abnormality and is an important contributor to chemoresistance in cancer therapy. To further characterize its biological significance, the response of Nrf2 on the synergistic cytotoxic effect of luteolin and tamoxifen was investigated in tamoxifen resistant breast cancer (MCF-7/TAM) cells. Tamoxifen-resistant human breast cancer cells (MCF7/TAM) were treated with tamoxifen and luteolin alone and in combination at different concentration for 24 h. The cell viability was detected by 3-(4,5-dimethiylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) assay. The transfection of siRNA was performed using Lipofectamine 2000 Reagent and the expression levels of Nuclear factor erythroid-2 p45-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1) were detected by Western blotting. Our results showed that combination treatment significantly sensitizes MCF-7/TAM cells to tamoxifen, which was accompanied by suppression of Nrf2 activation and decreased expression of HO-1. While overexpression of Nrf2 in tamoxifen resistant breast cancer cells conferred protection against the cytotoxicity caused by their combination, knockdown of Nrf2 expression using siRNA techniques enhanced their cytotoxic effect. These results suggested that luteolin in combination with tamoxifen can reversed tamoxifen resistance in MCF-7/TAM cells in synergic manner, at least in part, through suppression of Nrf2 signaling.
Subjects
Pharmaceutical SciencesChemistryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Chemical and Pharmaceutical Research.
Article · 12 Mar 2025
Studies on Exploring the Efficacy of Plant Based Silver Nanoparticles in Preventing Mercuric Toxicity on Blood
Article · 10 Mar 2025
Measurement of Malondialdehyde in Plasma by High Performance Liquid Chromatography Assay in Severe Cranial Trauma at The First Week of Admission: Comatose Patients
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Chemical and Pharmaceutical Research
- SubjectPharmaceutical Sciences
- SubjectChemistry
- BylineArticles whose byline prints “Mohammad Ali Esmaeili”